839714-89-5

Upstream product

• 51410-09-4 acetic acid-(3-acetyl-4-methoxy-anilide) 
• 868529-49-1 3-dimethylamino-1-(2'-methoxy-5'-acetamidophenyl)prop-2-en-1-one 
• 60-34-4 methylhydrazine 
• 64-19-7 acetic acid 
• 140226-35-3 1-methyl-5-(2'-methoxyphenyl)pyrazole 

Downstream Products

• 839713-95-0 4-methoxy-3-(2-methyl-2H-pyrazol-3-yl)phenylamine 
• 839714-90-8 N-[4-(2-dimethylamino-ethoxy)-3-(2-methyl-2H-pyrazol-3-yl)-phenyl]-acetamide 
• 839714-87-3 4-(2-dimethylamino-ethoxy)-3-(2-methyl-2H-pyrazol-3-yl)-phenylamine 
• 839713-36-9 Nelotanserin 
• 720702-45-4 3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenylamine 

Relevant academic research and scientific papers

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR

The present invention relates to processes for preparing phenyl-pyrazoles of Formula (I) and salts and pharmaceutical compositions thereof, useful as modulators of 5-HT2A serotonin receptor activity. The present invention also relates to interm

PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N’-[3-(1H-PYRAZOL-5-YL) PHENYL] UREAS AND INTERMEDIATES THEREOF

The present invention is directed to processes for the preparation of substituted phenylpyrazole ureas of Formula (I), that are useful as 5-HT2A serotonin receptor modulators for the treatment of disease.